Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 26,250
-200 (-0.76%)
At close: May 12, 2025, 3:30 PM KST
-22.68% (1Y)
| Market Cap | 1.33T |
| Revenue (ttm) | 138.94B |
| Net Income (ttm) | -1.80B |
| Shares Out | 50.74M |
| EPS (ttm) | -35.59 |
| PE Ratio | n/a |
| Forward PE | 188.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 201,859 |
| Average Volume | 176,496 |
| Open | 26,400 |
| Previous Close | 26,450 |
| Day's Range | 25,700 - 26,450 |
| 52-Week Range | 24,200 - 52,000 |
| Beta | 0.85 |
| RSI | 39.25 |
| Earnings Date | May 13, 2025 |